Breast Disease

Treatment

Five-Year Overall Survival of Female Patients With Breast Cancer by Raceᵃ (N= 11252)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
Caucasian (N= 9747)85407462605147183414
African-American (N= 1505)12971111896707503

ᵃSelf-Reported

Five-Year Overall Survival of Female Patients With Breast Cancer by Hormone Receptor Status (N= 9193)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
ER/PR Negative (N = 1778)155513091057801585
ER/PR Positive (N = 7415)64965763471837122729

ER= estrogen receptor, PR= progesterone receptor

Five-Year Overall Survival of Female Patients With Breast Cancer by HER2 Status (N= 8939)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
HER2 Negative (N = 7528)64415528437333062373
HER2 Positive (N = 1411)12601105906716502

HER2= human epidermal growth factor receptor 2

Five-Year Overall Survival of Female Patients With Stages I-III Breast Cancer by Estrogen Receptor, Progesterone Receptor, and HER2 Status (N= 8402)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
ER/PR Positive (N = 6220)54334805390630362203
HER2 Positive (N = 1214)1100969804639459
Triple-Negative (N = 968)844698547405289

ER= estrogen receptor, HER2= human epidermal growth factor receptor 2, PR= progesterone receptor

Five-Year Overall Survival of Female Patients With Stageᵃ 0 and I Breast Cancer (N= 7140)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
Stage 0 CC (N = 1924)1820164713961151879
Stage I CC (N = 5216)48114210336526842016

CC= Cleveland Clinic, NCDB= National Cancer Database

ᵃAJCC stage I-IV breast cancer

ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeons and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010.

Five-Year Overall Survival of Female Patients With Stageᵃ IIA and IIB Breast Cancer (N= 3510)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
Stage IIA (N = 2398)2213201617371350962
Stage IIB (N = 1112)1015892757587423

CC= Cleveland Clinic, NCDB= National Cancer Database

ᵃAJCC stage I-IV breast cancer

ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeons and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010.

Five-Year Overall Survival of Female Patients With Stageᵃ IIIA and IIIB Breast Cancer (N= 889)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
Stage IIIA (N = 611)565499415310218
Stage IIIB (N = 278)2221741167959

CC= Cleveland Clinic, NCDB= National Cancer Database

ᵃAJCC stage I-IV breast cancer

ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeons and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010.

Five-Year Overall Survival of Female Patients With Late-Stage Breast Cancer (N= 733)

2010-2020

Number at RiskYear 1Year 2Year 3Year 4Year 5
Stage IIIC (N = 217)1931511128657
Stage IV (N = 516)35426218111770

CC = Cleveland Clinic, NCDB = National Cancer Database

ᵃAJCC stage I-IV breast cancer

ᵇReferance group data from the National Cancer Database (Commission on Cancer of the American College of Surgeon and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010